Norges Bank’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.16M | Buy |
+630,938
| New | +$2.16M | ﹤0.01% | 1421 |
|
|
2025
Q1 | – | Sell |
-1,284,533
| Closed | -$3.76M | – | 10 |
|
|
2024
Q4 | $3.76M | Buy |
+1,284,533
| New | +$3.76M | ﹤0.01% | 1568 |
|
|
2024
Q3 | – | Sell |
-922,214
| Closed | -$2.73M | – | 10 |
|
|
2024
Q2 | $2.73M | Hold |
922,214
| – | – | ﹤0.01% | 1675 |
|
|
2024
Q1 | $4.18M | Hold |
922,214
| – | – | ﹤0.01% | 1651 |
|
|
2023
Q4 | $5.27M | Hold |
922,214
| – | – | ﹤0.01% | 1659 |
|
|
2023
Q3 | $4.24M | Sell |
922,214
-653,447
| -41% | -$3.01M | ﹤0.01% | 1713 |
|
|
2023
Q2 | $10.2M | Hold |
1,575,661
| – | – | ﹤0.01% | 1523 |
|
|
2023
Q1 | $11.9M | Buy |
1,575,661
+928,962
| +144% | +$7M | ﹤0.01% | 1504 |
|
|
2022
Q4 | $6.55M | Buy |
646,699
+124,289
| +24% | +$1.26M | ﹤0.01% | 1703 |
|
|
2022
Q3 | $5.17M | Buy |
522,410
+237,041
| +83% | +$2.34M | ﹤0.01% | 1753 |
|
|
2022
Q2 | $3.04M | Hold |
285,369
| – | – | ﹤0.01% | 1845 |
|
|
2022
Q1 | $2.78M | Hold |
285,369
| – | – | ﹤0.01% | 1947 |
|
|
2021
Q4 | $4.08M | Buy |
285,369
+165,175
| +137% | +$2.36M | ﹤0.01% | 1938 |
|
|
2021
Q3 | $2.41M | Buy |
120,194
+70,194
| +140% | +$1.41M | ﹤0.01% | 2025 |
|
|
2021
Q2 | $1.1M | Buy |
+50,000
| New | +$1.1M | ﹤0.01% | 2101 |
|